Skip to main content

Table 1 Patient Characteristics at Baseline, by Pulmonary Exacerbations During Study

From: Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

  No PE Any PE PE (No Hospitalization) PE (Hospitalization)
(n = 89) (n = 72) (n = 38) (n = 34)
Age, Mean (SD) 25.5 (10.2) 25.4 (8.8) 28.3 (7.8) 22.0 (8.7)
Female, N(%) 41 (46.1 %) 43 (59.7 %) 20 (52.6 %) 23 (67.6 %)
ppFEV1, Mean (SD) 65.8 (15.8) 60.8 (16.9) 60.9 (16.3) 60.6 (17.7)
BMI, N(%)     
 Normal Weight 75 (84.3 %) 57 (79.2 %) 28 (73.7 %) 29 (85.3 %)
 Obese 3 (3.4 %) 2 (2.8 %) 2 (5.3 %) 0 (0 %)
 Overweight 9 (10.1 %) 8 (11.1 %) 6 (15.8 %) 2 (5.9 %)
 Underweight 2 (2.3 %) 5 (6.9 %) 2 (5.3 %) 3 (8.8 %)
Sweat chloride, Mean (SD) 100.5 (9.5) 99.9 (11.3) 100 (11.4) 99.8 (11.2)
History of pancreatic insufficiency, N(%) 81 (91.0 %) 68 (94.4 %) 35 (92.1 %) 33 (97.1 %)
Use of inhaled cycling antibiotic, N(%) 37 (41.6) 19 (26.4 %) 8 (21.1 %) 11 (32.4 %)